跳到主要內容

Kayyem Jon Faiz 的 Form 4 申報

Inhibrx, Inc.,2022/12/22 申報

申報編號
0001739614-22-000132
申報時間
2022/12/22
交易日
2022/12/21
申報延遲
1 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 2 筆非衍生性交易。公開市場賣出合計 $25.7 萬。交易後 1 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Kayyem Jon FaizCIK 0001366268董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/12/21Common StockS賣出處分−7,541$26.87F2−$202,626.673,235,760間接
2022/12/21Common StockS賣出處分−1,959$27.61F4−$54,087.993,233,801間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

The shares were sold in multiple transactions at prices ranging from $26.385 to $27.38, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F4

The shares were sold in multiple transactions at prices ranging from $27.39 to $27.74, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)